Remedy Entertainment may not have cracked the formula for turning every one of its games into a huge commercial smash just yet, but Control Resonant could well change that. Released on 24 September 2026 on PC, PS5 and Xbox Series, the game has just passed the one million copies sold mark in only three weeks. That result sees it overtake Alan Wake 2 and become the fastest-selling game in the Finnish studio's entire history. It's a performance that isn't quite enough to guarantee profitability yet, but it's a first encouraging sign for a company whose financial situation remains a sensitive subject.
One million sales in three weeks
Remedy confirmed the news in a post on social media, specifying that Control Resonant had passed a million copies sold across all platforms. The game had already enjoyed a warm reception from press and players alike, and its early commercial results seem to bear that interest out. On Steam, it reportedly shifted close to 300,000 copies in its first week alone, for roughly $12.7 million in revenue generated on the platform, according to estimates from Alinea Analytics.
That figure does need putting into perspective when set against the market's biggest releases, which can hit the same threshold in a matter of days, or even hours. But for Remedy, whose productions tend to rest on singular worlds and a demanding narrative approach, a million sales in three weeks is a record nonetheless. Alan Wake 2, widely praised on its release in 2023 and awarded for its storytelling and art direction, took two months to reach the same milestone. At the time it beat the initial performance of the first Control, becoming the studio's fastest-selling game until its sequel came along.
Profitability remains the real challenge
Beyond a new record that's good for morale and makes for a fine public image, Remedy Entertainment above all needs to turn those sales into lasting profits. Alan Wake 2 had to pass the two million copies mark before it started making the studio any money, more than a year after its release. That kind of delay says a lot about the weight of development costs in an industry where even critically acclaimed games aren't guaranteed to turn a profit quickly.
This is exactly where Jean-Charles Gaudechon, appointed Remedy's chief executive last February, is expected to deliver. The new boss has made profitable growth a priority for the Finnish studio, whose ambitions must now be matched by more solid financial results. He described Control Resonant's million sales as a “very good start”, without releasing detailed data for now on the game's revenue or how sales break down across the various platforms. Either way, Control Resonant has enjoyed a faster launch than its predecessors, with both critical and commercial reception appearing to be in its favour. Whether that momentum holds over the coming months remains to be seen — and in the meantime, you can read screenactu's review right here. It's by Fabien Pellegrini.
